Daily cardiology
By Daily Cardiology Academy
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by Daily Cardiology Academy
Category: Medicine
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 3
Reviews: 0
Episodes: 556
Description
to enjoy learning and progressing in cardiometabolic practice
| Episode | Date |
|---|---|
|
ACC.24 Congress Coverage: SMART Trial
|
May 11, 2024 |
|
ACC.24 Congress Coverage: Transcatheter or Surgical Treatment of Aortic-Valve Stenosis
|
May 11, 2024 |
|
ACC.24 Congress Coverage: Empagliflozin after Acute Myocardial Infarction
|
May 11, 2024 |
|
ACC.24 Congress Coverage: KARDIA-2 trial
|
May 11, 2024 |
|
ACC.24 Congress Coverage: Safety and Efficacy of Ninerafaxstat in Patients With Nonobstructive HCM
|
May 03, 2024 |
|
ACC.24 Congress Coverage: A Web Application for Consumer Access to Nonprescription Statins
|
May 03, 2024 |
|
ACC.24 Congress Coverage: BE ACTIVE Trial
|
May 03, 2024 |
|
ACC.24 Congress Coverage: REDUCE-IT trial
|
May 03, 2024 |
|
ACC.24 Congress Coverage: VICTORION-INITIATE trial
|
May 03, 2024 |
|
ACC.24 Congress Coverage: Interatrial shunt therapy in advanced heart failure
|
May 03, 2024 |
|
ACC.24 Congress Coverage: Semaglutide in Patients with Obesity-Related Heart Failure and DM
|
Apr 25, 2024 |
|
ACC.24 Congress Coverage: The Trial to Assess Chelation Therapy 2
|
Apr 25, 2024 |
|
ACC.24 Congress Coverage: Olezarsen for Hypertriglyceridemia in Patients at High Cardiovascular Risk
|
Apr 25, 2024 |
|
ACC.24 Congress Coverage: Microaxial Flow Pump vs Standard Care in Infarct-Related Cardiogenic Shock
|
Apr 25, 2024 |
|
ACC.24 Congress Coverage: Apolipoprotein A1 Infusions and Cardiovascular Outcomes after Acute MI
|
Apr 25, 2024 |
|
ACC.24 Congress Coverage: Effect of SGLT2i in Adults With Congenital Heart Disease
|
Apr 25, 2024 |
|
ACC.24 Congress Coverage: Trial of a Selective Aldose Reductase Inhibitor in Diabetic Cardiomyopathy
|
Apr 25, 2024 |
|
ACC.24 Congress Coverage: ORBITA-COSMIC Trial
|
Apr 20, 2024 |
|
ACC.24 Congress Coverage: REDUCE-AMI Trial
|
Apr 20, 2024 |
|
ACC.24 Congress Coverage: Mandibular Advancement Device vs CPAP in Obstructive Sleep Apnea
|
Apr 20, 2024 |
|
Impact: Evaluation of a Best-Practice Advisory for Primary Aldosteronism Screening
|
Apr 15, 2024 |
|
Case Discussion 111 Answer: Antiplatelet therapy in CCS Patients Undergoing CABG
|
Apr 15, 2024 |
|
Impact: Why Do GLP-1 Drugs Stop Working, and What to Do About It?
|
Apr 15, 2024 |
|
Impact: Risk of Death in Patients With Coronary Artery Disease Taking Nitrates and PDE-5 Inhibitors
|
Apr 15, 2024 |
|
Case Discussion 115 Answer: Hormonal Contraceptive Medications in Patients with Hypertension
|
Apr 15, 2024 |
|
Cardiology Online Grand Round: The Art of Optimal Medical Therapy for Heart Failure
|
Apr 04, 2024 |
|
Case Discussion 114 Answer: FLOT chemotherapy regimen and cardiovascular system
|
Mar 29, 2024 |
|
Light Rounds Volume 7: Elderly gentleman with HTN, ICMP and SCAF
|
Mar 29, 2024 |
|
Case Discussion 113 Answer: Considerations before initiating antihypertensive treatment
|
Mar 05, 2024 |
|
Case Discussion 112 Answer: Considerations for MR Imaging in Patients with Prosthetic Heart Valves
|
Mar 05, 2024 |
|
Case Discussion 108 Answer: Screening for HCM in patients with positive family history
|
Mar 05, 2024 |
|
Impact: Contemporary Management and Outcomes of Patients With High-Risk Pulmonary Embolism
|
Mar 05, 2024 |
|
Impact: Mortality After Takotsubo – Comparison With MI and General Population
|
Feb 18, 2024 |
|
Case Discussion 107 Answer: SCD risk evaluation and the use of cardiac MRI in patients with HCM
|
Feb 18, 2024 |
|
Impact: Clopidogrel vs Aspirin Monotherapy Beyond 1 Year After Percutaneous Coronary Intervention
|
Jan 30, 2024 |
|
Impact: Validity of a speech analysis app for the prediction of HF worseningImpact: Speech analysis
|
Jan 30, 2024 |
|
Case Discussion 109 Answer: GI protection in patients on single antiplatelet therapy
|
Jan 30, 2024 |
|
Case Discussion 110 Answer: Tapering off medical therapy in acute idiopathic pericarditis
|
Jan 30, 2024 |
|
Hypertension and Hyperlipidemia Academy, No. 15 - Part 2
|
Jan 19, 2024 |
|
Hypertension and Hyperlipidemia Academy, No. 15 - Part 1
|
Jan 18, 2024 |
|
Diabeat, 9th session: is Metformin still the champion for T2D and heart disease? a debate: Pros
|
Jan 10, 2024 |
|
Diabeat, 9th session: is Metformin still the champion for T2D and heart disease? a debate: Cons
|
Jan 10, 2024 |
|
Diabeat: the 9th diabetes masterclass for cardiologists, case-based discussion
|
Jan 02, 2024 |
|
Hypertension and Hyperlipidemia Academy, No. 14 - Part 2
|
Jan 01, 2024 |
|
Hypertension and Hyperlipidemia Academy, No. 14 - Part 1
|
Jan 01, 2024 |
|
Case Discussion 98 Answer: Long term anticoagulation after cerebral venous sinus thrombosis
|
Dec 11, 2023 |
|
H&H Academy in 7-minutes, Episode 1
|
Dec 11, 2023 |
|
AHA23 Congress Coverage: A Placebo-Controlled Trial of PCI for Stable Angina: The ORBITA-2 trial
|
Dec 04, 2023 |
|
Case Discussion 103 Answer: Approach to the management of Ascending Aorta Dilation
|
Dec 04, 2023 |
|
AHA23 Congress Coverage: Impact of Female Sex on Cardiogenic Shock Outcomes
|
Dec 04, 2023 |
|
AHA23 Congress Coverage: Lepodisiran Dose-Ascending Trial
|
Dec 04, 2023 |
|
AHA23 Congress Coverage: Daily Marijuana Use is Associated With HF: “All of Us” Research Program
|
Dec 03, 2023 |
|
AHA23 Congress Coverage: Long-Term BP Control After Hypertensive Pregnancy: The POP-HT trial
|
Dec 03, 2023 |
|
AHA23 Congress Coverage: Hypertension Treatment and Risk of Dementia
|
Nov 20, 2023 |
|
AHA23 Congress Coverage: Apixaban for Stroke Prevention in Subclinical AF: ARTESIA trial
|
Nov 20, 2023 |
|
AHA23 Congress Coverage: Semaglutide and Cardiovascular Outcomes in Obesity without DM: SELECT trial
|
Nov 20, 2023 |
|
AHA23 Congress Coverage: Dapagliflozin in Myocardial Infarction without DM or HF: DAPA-MI trial
|
Nov 20, 2023 |
|
AHA23 Congress Coverage: Restrictive or Liberal Transfusion Strategy in MI and Anemia: MINT trial
|
Nov 20, 2023 |
|
Case Discussion 102: Diagnosis and management of Retroaortic Anomalous Coronary Artery
|
Nov 20, 2023 |
|
Case Discussion 101: ICD implantation in patients with non-ischemic dilated cardiomyopathy
|
Nov 04, 2023 |
|
Case Discussion 100: Management of asymptomatic congenital anomaly of the right coronary artery
|
Oct 31, 2023 |
|
Stage 1 hypertension: treat or not?
|
Oct 30, 2023 |
|
Light Rounds Volume 6: Elderly gentleman with T2D, CAD and foot ulcer
|
Oct 22, 2023 |
|
Light Rounds Volume 5: 22 Y/O lady with frequent PVCs
|
Oct 16, 2023 |
|
Impact: When Does a Calcium Score Equate to Secondary Prevention?
|
Oct 10, 2023 |
|
Case Discussion 99: P2Y12 inhibitors in STEMI patients treated with Fibrinolytics and undergoing PCI
|
Oct 10, 2023 |
|
AI and Medicine, a chat with the creator of DocSplain
|
Sep 24, 2023 |
|
ESC 2023 Congress Coverage: 2023 ESC Guidelines for the management of CVD in patients with diabetes
|
Sep 18, 2023 |
|
ESC 2023 Congress Coverage: 2023 ESC Guidelines for the management of endocarditis
|
Sep 18, 2023 |
|
ESC 2023 Congress Coverage: 2023 ESC Guidelines for the management of cardiomyopathies
|
Sep 18, 2023 |
|
ESC 2023 Congress Coverage: 2023 ESC Guidelines for the management of acute coronary syndromes
|
Sep 10, 2023 |
|
ESC 2023 Congress Coverage: 2023 Focused Update of the 2021 HF Guideline
|
Sep 10, 2023 |
|
ESC 2023 Congress Coverage: OPT-BIRISK
|
Sep 02, 2023 |
|
Stage 1 hypertension at a glance
|
Sep 02, 2023 |
|
ESC 2023 Congress Coverage: HEART-FID
|
Sep 02, 2023 |
|
ESC 2023 Congress Coverage: BUDAPEST-CRT Upgrade
|
Sep 02, 2023 |
|
ESC 2023 Congress Coverage: STOP-DAPT 3
|
Sep 02, 2023 |
|
ESC 2023 Congress Coverage: RED-CVD
|
Sep 02, 2023 |
|
ESC 2023 Congress Coverage: ARAMIS
|
Sep 02, 2023 |
|
Overview of ESC 2023 Congress
|
Sep 02, 2023 |
|
ESC 2023 Congress Coverage: ATTRibute CM
|
Sep 02, 2023 |
|
ESC 2023 Congress Coverage: ONCO-DVT
|
Sep 02, 2023 |
|
ESC 2023 Congress Coverage: FIRE
|
Sep 02, 2023 |
|
ESC 2023 Congress Coverage: ADVENT
|
Sep 02, 2023 |
|
ESC 2023 Congress Coverage: RIGHT
|
Sep 02, 2023 |
|
ESC 2023 Congress Coverage: ARREST
|
Sep 02, 2023 |
|
ESC 2023 Congress Coverage: NOAH-AFNET 6
|
Sep 02, 2023 |
|
ESC 2023 Congress Coverage: MULTISTARS AMI
|
Sep 02, 2023 |
|
ESC 2023 Congress Coverage: COP-AF
|
Sep 02, 2023 |
|
ESC 2023 Congress Coverage: CASTLE-HTx
|
Sep 02, 2023 |
|
ESC 2023 Congress Coverage: STEP-HFpEF
|
Sep 02, 2023 |
|
ESC 2023 Congress Coverage: DICTATE-AHF
|
Sep 02, 2023 |
|
ESC 2023 Congress Coverage: QUEST
|
Sep 02, 2023 |
|
ESC 2023 Congress Coverage: NITRATE-CIN
|
Sep 02, 2023 |
|
ESC 2023 Congress Coverage: PUSH-AHF
|
Sep 02, 2023 |
|
Impact: Clinical Outcomes of Calcium Channel Blockers versus Beta Blockers after Acute MI
|
Aug 24, 2023 |
|
Case Discussion 76 Answer
|
Aug 24, 2023 |
|
Apical Hypertrophic Cardiomyopathy, a narrative review
|
Aug 24, 2023 |
|
Case Discussion 97 Answer
|
Aug 24, 2023 |
|
Impact: Zilebesiran, an RNA Interference Therapeutic Agent for Hypertension
|
Aug 17, 2023 |
|
Impact: Combination lipid-lowering therapy after PCI
|
Aug 12, 2023 |
|
Hypertension and Hyperlipidemia Academy Session - Part 1
|
Aug 12, 2023 |
|
Case Discussion 95 Answer
|
Aug 12, 2023 |
|
Hypertension and Hyperlipidemia Academy Session - Part 2
|
Aug 12, 2023 |
|
Impact: Early versus Later Anticoagulation for Stroke with Atrial Fibrillation
|
Aug 12, 2023 |
|
NEJM Knowledge plus Case Discussion
|
Jul 31, 2023 |
|
Daily Cardiology Symposium 1402 Day 2 Panel 1
|
Jul 31, 2023 |
|
Daily Cardiology’s Young Cardiologist Award 1402 Final
|
Jul 31, 2023 |
|
Daily Cardiology Symposium 1402 Day 2 Panel 4
|
Jul 31, 2023 |
|
Daily Cardiology Symposium 1402 Day 2 Panel 2
|
Jul 31, 2023 |
|
Daily Cardiology Symposium 1402 Day 2 Panel 3
|
Jul 31, 2023 |
|
Daily Cardiology Symposium 1402 Day 1 Panel 2
|
Jul 31, 2023 |
|
Daily Cardiology Symposium 1402 Day 1 Panel 4
|
Jul 31, 2023 |
|
Daily Cardiology Symposium 1402 Day 1 Panel 3
|
Jul 31, 2023 |
|
Daily Cardiology Symposium 1402 Day 1 Panel 1
|
Jul 31, 2023 |
|
Daily Cardiology Symposium 1402 Welcome Remarks
|
Jul 31, 2023 |
|
Case Discussion 78 Answer
|
Jul 24, 2023 |
|
Case Discussion 93 Answer
|
Jul 24, 2023 |
|
Light Rounds Volume 4: middle-aged gentleman with HTN, T2D and erythrocytosis
|
Jul 16, 2023 |
|
Case Discussion 84 Answer
|
Jul 16, 2023 |
|
Case Discussion 88 Answer
|
Jul 16, 2023 |
|
Vision: Adults with fasting TG=150-500mg with ACVD or DM
|
Jul 16, 2023 |
|
Case Discussion 85 Answer
|
Jul 16, 2023 |
|
Case Discussion 79 Answer
|
Jul 01, 2023 |
|
Case Discussion 91 Answer
|
Jul 01, 2023 |
|
Case Discussion 87 Answer
|
Jun 25, 2023 |
|
Cardiac considerations and monitoring in patients receiving Acetylcholinesterase inhibitors
|
Jun 17, 2023 |
|
Case Discussion 75 Answer
|
Jun 17, 2023 |
|
PROMIS-II trial explained
|
Jun 17, 2023 |
|
Case Discussion 72 Answer
|
Jun 17, 2023 |
|
Case Discussion 82 Answer
|
Jun 10, 2023 |
|
Light Rounds Volume 3: elderly gentleman with ICMP and LV thrombus
|
Jun 10, 2023 |
|
InstaCath Conference 20 Answer
|
Jun 02, 2023 |
|
Case Discussion 77 Answer
|
Jun 02, 2023 |
|
Hypertension and Hyperlipidemia Academy: clinical tips for nurses and non-physicians - Part 2
|
Jun 02, 2023 |
|
Case Discussion 80 Answer
|
Jun 02, 2023 |
|
Hypertension and Hyperlipidemia Academy: clinical tips for nurses and non-physicians - Part 1
|
Jun 02, 2023 |
|
InstaCath Conference 21 Answer
|
May 27, 2023 |
|
Case Discussion 81 Answer
|
May 27, 2023 |
|
American College of Cardiology (ACC) 2023 Congress Coverage - Part 2
|
May 27, 2023 |
|
American College of Cardiology (ACC) 2023 Congress Coverage - Part 1
|
May 27, 2023 |
|
Case Discussion 73 Answer
|
May 27, 2023 |
|
Hypertension and Hyperlipidemia Academy 12th session - Part2
|
May 27, 2023 |
|
Case Discussion 74 Answer
|
May 27, 2023 |
|
Hypertension and Hyperlipidemia Academy 12th session - Part 1
|
May 26, 2023 |
|
Light Rounds Volume 2: young gentleman with recurrent syncope
|
May 12, 2023 |
|
Should ACS patients start a PCSK9i in the hospital?
|
May 12, 2023 |
|
Impact: Variation in Renal Function Following Transition to Sacubitril/Valsartan in Patients With HF
|
May 12, 2023 |
|
InstaCath Conference Number 22 Answer
|
May 12, 2023 |
|
Vision: Adults with fasting TG=150-500mg without ACVD or DM
|
Apr 15, 2023 |
|
Dyslipidemia management in patients with diabetes
|
Apr 08, 2023 |
|
Case Discussion 71 Answer
|
Mar 14, 2023 |
|
Hypertension and Hyperlipidemia Academy: Smoothing the path to CVD risk reduction - Part 2
|
Mar 14, 2023 |
|
Light Rounds Volume 1: a middle-aged lady with WPW in ECG
|
Mar 14, 2023 |
|
Hypertension and Hyperlipidemia Academy: Smoothing the path to CVD risk reduction - Part 1
|
Mar 14, 2023 |
|
Impact: Healthy Eating Patterns and Risk of Total and Cause-Specific Mortality
|
Feb 22, 2023 |
|
CardioWatch, Season 2 Episode 6
|
Feb 22, 2023 |
|
Impact: Survival difference in dyspnea and chest pain as an initial symptom of NSTEMI
|
Feb 09, 2023 |
|
Case Discussion 70: Potassium supplementation in mild to moderate Hypokalemia
|
Jan 23, 2023 |
|
Impact: Management of ACS in older adults, an AHA statement
|
Dec 26, 2022 |
|
Impact: single chest x-ray could predict 10-year CVD risk
|
Dec 26, 2022 |
|
Case Discussion No. 68 Answer: anticoagulation in pregnancy
|
Dec 26, 2022 |
|
PANTHER: Clopidogrel overcoming the old rival
|
Dec 11, 2022 |
|
CardioWatch, Season 2 Episode 5
|
Dec 11, 2022 |
|
Impact: The association between dairy intake and risk of CVD in patients with stable angina pectoris
|
Nov 23, 2022 |
|
Impact: The impact of coffee subtypes on incident CVD, arrhythmias, and mortality
|
Nov 17, 2022 |
|
Impact: Experts Express Caution Over Type 2 Diabetes-Tea Drinking Claim
|
Nov 17, 2022 |
|
Impact: Dual antiplatelet therapy with Ticagrelor and graft failure after CABG
|
Nov 10, 2022 |
|
Impact: Improved Likelihood of Survival With the Use of the Head-Up CPR Bundle for Non-Shockable Car
|
Nov 03, 2022 |
|
Impact: Acetaminophen in comparison to NSAIDs in cardiovascular diseases
|
Nov 03, 2022 |
|
Impact: RADIANCE II: Pivotal study, renal denervation for stage II Hypertension
|
Nov 03, 2022 |
|
Impact: Pulmonary Artery Denervation for Pulmonary Arterial Hypertension
|
Oct 23, 2022 |
|
Impact: Association of Sacubitril/Valsartan administration and the severity of functional MR in HFrE
|
Oct 23, 2022 |
|
Impact: Effect of statin therapy on muscle symptoms
|
Oct 10, 2022 |
|
Case Discussion 59 Answer
|
Sep 26, 2022 |
|
Vision: Vol. 3, Antithrombotic therapy for surgical bioprosthetic valves and valve repair
|
Sep 26, 2022 |
|
Case Discussion 52 Answer
|
Sep 26, 2022 |
|
Case Discussion 60 Answer
|
Sep 26, 2022 |
|
Case Discussion 57 Answer
|
Sep 26, 2022 |
|
Care Gaps in Adherence to Heart Failure Guidelines
|
Sep 17, 2022 |
|
Instacath Conference 18
|
Sep 17, 2022 |
|
Umbrella: Heart Failure, Panel 1, Pharmacotherapy in HFrEF
|
Sep 16, 2022 |
|
Umbrella: Heart Failure, Panel 2, Non-pharmacologic Approach to HF Management
|
Sep 16, 2022 |
|
Umbrella: Heart Failure, Panel 4, Heart Failure with EF more than 40%
|
Sep 16, 2022 |
|
Umbrella: Heart Failure, Panel 3, Acute Decompensated Heart Failure
|
Sep 16, 2022 |
|
Case Discussion 56 Answer
|
Sep 10, 2022 |
|
ESC 2022 congress coverage: ALL-HEART trial
|
Sep 02, 2022 |
|
ESC 2022 congress coverage: INVICTUS trial
|
Sep 02, 2022 |
|
ESC 2022 congress coverage: DANCAVAS trial
|
Sep 02, 2022 |
|
ESC 2022 congress coverage: DELIVER trial
|
Sep 02, 2022 |
|
ESC 2022 congress coverage: DANFLU-1 trial
|
Sep 02, 2022 |
|
ESC 2022 congress coverage: REVIVED trial
|
Sep 02, 2022 |
|
ESC 2022 congress coverage: TIME trial
|
Aug 27, 2022 |
|
ESC 2022 congress coverage: SECURE trial
|
Aug 27, 2022 |
|
Hypertension and Hyperlipidemia Academy No. 10 - Part 2
|
Aug 27, 2022 |
|
ESC 2022 congress coverage: PERSPECTIVE trial
|
Aug 27, 2022 |
|
A preview of ESC congress 2022
|
Aug 27, 2022 |
|
ESC 2022 congress coverage: ADVOR trial
|
Aug 27, 2022 |
|
Hypertension and Hyperlipidemia Academy No. 10 - Part 1
|
Aug 27, 2022 |
|
Case Discussion 50 Answer
|
Aug 20, 2022 |
|
CardioWatch, Season 2 Episode 4
|
Aug 13, 2022 |
|
Case Discussion 47 Answer
|
Aug 13, 2022 |
|
Antiplatelet Journal Scan
|
Aug 06, 2022 |
|
Instacath Conference 17
|
Aug 06, 2022 |
|
Hypertension and Hyperlipidemia Academy, 10: for non-physician healthcare profesionals - part 1
|
Aug 04, 2022 |
|
Case Discussion 51 Answer
|
Aug 03, 2022 |
|
Case Discussion 49 Answer
|
Aug 03, 2022 |
|
Case Discussion 48 Answer - Case Discussion 48 Answer
|
Aug 03, 2022 |
|
Case Discussion 48 Answer - Case Discussion 48 Answer
|
Aug 03, 2022 |
|
Vision: Vol. 2, Distal DVTs
|
Aug 03, 2022 |
|
InstaCath Conference 15
|
Aug 03, 2022 |
|
Hypertension and Hyperlipidemia Academy, 10: for non-physician healthcare professionals - part 2
|
Aug 03, 2022 |
|
Case Discussion 46 Answer
|
Jul 21, 2022 |
|
Familial hypercholesterolemia, a narrative review, part 3: management
|
Jul 16, 2022 |
|
Vision: Vol. 1, What is Lp(a)?
|
Jul 16, 2022 |
|
Hypertension and Hyperlipidemia Academy, 9th session - Part 2
|
Jul 15, 2022 |
|
DCS 1401, Mitral regurgitation
|
Jul 13, 2022 |
|
Hypertension and Hyperlipidemia Academy, 9th session - Part 1
|
Jul 13, 2022 |
|
InstaCath Conference 16
|
Jul 13, 2022 |
|
DCS 1401, Aortic insufficiency
|
Jul 12, 2022 |
|
DCS 1401, Prosthetic valve malfunction
|
Jul 12, 2022 |
|
DCS 1401, Permanent pacemakers
|
Jul 12, 2022 |
|
DCS 1401, Heart Failure With Improved EF
|
Jul 12, 2022 |
|
DCS 1401, Heart Failure with preserved EF
|
Jul 12, 2022 |
|
DCS 1401, Acute Decompensated Heart Failure
|
Jul 12, 2022 |
|
DCS 1401, Implantable cardioverter defibrillators
|
Jul 09, 2022 |
|
DCS 1401, Rhythm control strategies in AF
|
Jul 08, 2022 |
|
DCS 1401, Cardiac resynchronization therapy
|
Jul 08, 2022 |
|
DCS 1401, Atrioventricular nodal reentry tachycardia (AVNRT)
|
Jul 08, 2022 |
|
DCS 1401, Premature ventricular complexes
|
Jul 08, 2022 |
|
DCS 1401, Abdominal Aortic aneurysm
|
Jul 08, 2022 |
|
DCS 1401, Peripheral arterial disease
|
Jul 08, 2022 |
|
DCS 1401, Carotid Artery Stenosis
|
Jul 08, 2022 |
|
DCS 1401, VTE prophylaxis in COVID-19
|
Jul 08, 2022 |
|
DCS 1401, VTE prophylaxis in surgical patients
|
Jul 08, 2022 |
|
DCS 1401, Chronic Coronary Syndrome
|
Jul 08, 2022 |
|
DCS 1401, VTE prophylaxis in pregnancy
|
Jul 08, 2022 |
|
DCS 1401, Non-ST-elevation acute coronary syndrome
|
Jul 08, 2022 |
|
DCS 1401, Dyslipidemia
|
Jul 07, 2022 |
|
DCS 1401, ST-elevation Myocardial Infarction
|
Jul 07, 2022 |
|
DCS 1401, Hypertension
|
Jul 06, 2022 |
|
DCS 1401, Diabetes mellitus
|
Jul 03, 2022 |
|
Daily Cardiology Symposium 1401, Day 2 Panel 4: Valvular heart disease
|
Jul 03, 2022 |
|
Daily Cardiology Symposium 1401, Day 1 Panel 3: Venous thromboembolism (VTE) prophylaxis
|
Jul 03, 2022 |
|
Daily Cardiology Symposium 1401, Day 2 Panel 3: Heart Failure
|
Jul 02, 2022 |
|
Daily Cardiology Symposium 1401, Day 2 Panel 2: Device therapy in cardiovascular diseases
|
Jul 02, 2022 |
|
Daily Cardiology Symposium 1401, Day 1 Panel 4: Peripheral vascular diseases
|
Jul 02, 2022 |
|
Daily Cardiology Symposium 1401, Day 2 Panel 1: Arrhythmia
|
Jul 02, 2022 |
|
Daily Cardiology Symposium 1401, Day 1 Panel 2: Revascularization in CAD
|
Jul 02, 2022 |
|
Daily Cardiology Symposium 1401, Day 1 Panel 1: Pharmacotherapy in CAD
|
Jul 01, 2022 |
|
Case discussion No. 44
|
Jul 01, 2022 |
|
Daily Cardiology Symposium 1401, opening remarks
|
Jul 01, 2022 |
|
Case discussion No. 45
|
Jun 17, 2022 |
|
InstaCath Conference 14
|
Jun 10, 2022 |
|
CardioWatch, Season 2 Episode 3
|
Jun 10, 2022 |
|
Case discussion No. 41
|
Jun 06, 2022 |
|
Hypertension and Hyperlipidemia Academy, 8th session
|
Jun 06, 2022 |
|
Case discussion No. 42
|
Jun 06, 2022 |
|
CardioWatch, Season 2 Episode 2
|
May 21, 2022 |
|
Case discussion No. 43
|
May 21, 2022 |
|
American College of Cardiology (ACC) congress 2022 landmark trials review
|
May 06, 2022 |
|
TicaHub 2: Ticagrelor in clinical trials
|
May 06, 2022 |
|
At a glance: Ticagrelor and prevention of recurrent thrombotic events in CCS
|
Apr 29, 2022 |
|
CardioWatch, Season 2 Episode 1
|
Apr 08, 2022 |
|
Case discussion No. 40
|
Mar 17, 2022 |
|
Hypertension and Hyperlipidemia Academy, 7th session
|
Mar 17, 2022 |
|
Familial hypercholesterolemia, a narrative review, part 2: diagnosis and screening
|
Mar 17, 2022 |
|
Cardiometabolic grand round: session 6
|
Mar 17, 2022 |
|
Umbrella: Hypertension, secondary hypertension
|
Mar 12, 2022 |
|
Umbrella: Hypertension, hypertension and pregnancy
|
Mar 12, 2022 |
|
Umbrella: Hypertension, Acute severe hypertension
|
Mar 12, 2022 |
|
Umbrella: Hypertension, Challenges in the diagnosis & management of HTN
|
Mar 12, 2022 |
|
HeartCast 5: practical approach to the treatment of HFrEF
|
Mar 06, 2022 |
|
HeartCast 4: practical approach to the treatment of HFrEF
|
Feb 11, 2022 |
|
which prophylaxis? for whom? VTE prophylaxis panel discussion
|
Feb 07, 2022 |
|
Hypertension and Hyperlipidemia Academy: for nurses and medical assistants
|
Feb 07, 2022 |
|
DiaBeat: The Beating Heart of Diabetes (2nd session)
|
Jan 29, 2022 |
|
Cardiometabolic Grand Round (1)
|
Jan 28, 2022 |
|
Umbrella Heart and Stroke: session 3, Atrial fibrillation screening
|
Jan 28, 2022 |
|
Umbrella Heart and Stroke: session 2, carotid stenosis and stroke
|
Jan 28, 2022 |
|
Umbrella Heart and Stroke: session 4, Antithrombotic therapy for the secondary prevention of stroke
|
Jan 28, 2022 |
|
DCS 1400: session 6, Arrhythmia
|
Jan 27, 2022 |
|
Umbrella, CCS 1
|
Jan 27, 2022 |
|
Umbrella, CCS 2
|
Jan 27, 2022 |
|
Umbrella, CCS 3
|
Jan 27, 2022 |
|
DCS 1400: session 8, Valvular Heart disease
|
Jan 27, 2022 |
|
DCS 1400: session 5, HF
|
Jan 27, 2022 |
|
DCS 1400: session 3, CCS
|
Jan 27, 2022 |
|
DCS 1400: session 1, HTN and DLP
|
Jan 27, 2022 |
|
DCS 1400: session 2, Diabetes for cardiologists
|
Jan 27, 2022 |
|
DCS 1400: welcome remarks
|
Jan 27, 2022 |
|
17th ECG Workshop: Broad and Narrow
|
Jan 27, 2022 |
|
ECG Challenge (4)
|
Jan 27, 2022 |
|
Pharmacological approach to ACS management in patients on DOAC
|
Jan 27, 2022 |
|
Finding the optimal thromboprophylaxis regimen in patients with COVID-19
|
Jan 27, 2022 |
|
DCS 1400: session 7, VTE
|
Jan 27, 2022 |
|
DCS 1400: session 4, ACS
|
Jan 27, 2022 |
|
Update on IVC Filters
|
Jan 27, 2022 |
|
Daily Cardiology Conversation
|
Jan 27, 2022 |
|
Cardiology Close-Up (8)
|
Jan 27, 2022 |
|
Cardiology Close-Up (10)
|
Jan 27, 2022 |
|
Cardiology Close-Up (3)
|
Jan 27, 2022 |
|
Cardiology Close-Up (5)
|
Jan 27, 2022 |
|
Cardiology Close-Up (2)
|
Jan 27, 2022 |
|
Cardiology Close-Up (9)
|
Jan 27, 2022 |
|
Cardiology Close-Up (4)
|
Jan 27, 2022 |
|
Cardiology Close-Up (6)
|
Jan 27, 2022 |
|
Cardiology Close-Up (7)
|
Jan 27, 2022 |
|
Cardiology Close-Up (1)
|
Jan 27, 2022 |
|
Case Discussion (3)
|
Jan 26, 2022 |
|
Insta Cath Conference (9)
|
Jan 26, 2022 |
|
Insta Cath Conference (8)
|
Jan 26, 2022 |
|
Insta Cath Conference (7)
|
Jan 26, 2022 |
|
Case Discussion (4)
|
Jan 26, 2022 |
|
Case Discussion (5)
|
Jan 26, 2022 |
|
Case Discussion (29)
|
Jan 26, 2022 |
|
Insta Cath Conference (11)
|
Jan 26, 2022 |
|
Case Discussion (17)
|
Jan 26, 2022 |
|
Case Discussion (18)
|
Jan 26, 2022 |
|
Case Discussion (24)
|
Jan 26, 2022 |
|
Insta Cath Conference (10) – Second Opinion
|
Jan 26, 2022 |
|
Case Discussion (19)
|
Jan 26, 2022 |
|
Case Discussion (16)
|
Jan 26, 2022 |
|
Case Discussion (20)
|
Jan 26, 2022 |
|
Case Discussion (23)
|
Jan 26, 2022 |
|
Case Discussion (15)
|
Jan 26, 2022 |
|
Case Discussion (28)
|
Jan 26, 2022 |
|
Case Discussion (31)
|
Jan 26, 2022 |
|
Case Discussion (37)
|
Jan 26, 2022 |
|
Case Discussion (21)
|
Jan 26, 2022 |
|
Case Discussion (27)
|
Jan 26, 2022 |
|
Case Discussion (30)
|
Jan 26, 2022 |
|
Insta Cath Conference (10)
|
Jan 26, 2022 |
|
Insta Cath Conference (12)
|
Jan 26, 2022 |
|
Insta Cath Conference (13)
|
Jan 26, 2022 |
|
Insta Cath Conference (13)- Second Opinion
|
Jan 26, 2022 |
|
Case Discussion (12)
|
Jan 26, 2022 |
|
Case Discussion (10)
|
Jan 26, 2022 |
|
Case Discussion (13)
|
Jan 26, 2022 |
|
Case Discussion (14)
|
Jan 26, 2022 |
|
Case Discussion (9)
|
Jan 26, 2022 |
|
Case Discussion (11)
|
Jan 26, 2022 |
|
Case Discussion (7)
|
Jan 26, 2022 |
|
Insta Cath Conference (3)
|
Jan 25, 2022 |
|
Case Discussion (22)
|
Jan 25, 2022 |
|
Insta Cath Conference (4)
|
Jan 25, 2022 |
|
Case Discussion (26)
|
Jan 25, 2022 |
|
Insta Cath Conference (2)
|
Jan 25, 2022 |
|
Insta Cath Conference (5)
|
Jan 25, 2022 |
|
Insta Cath Conference (3) – Second Opinion
|
Jan 25, 2022 |
|
Case Discussion (8)
|
Jan 25, 2022 |
|
Familial hypercholesterolemia, a narrative review, part 1: definition and burden
|
Jan 25, 2022 |
|
Insta Cath Conference (6)
|
Jan 25, 2022 |
|
Insta Cath Conference (1)
|
Jan 25, 2022 |
|
Case Discussion (6)
|
Jan 25, 2022 |
|
HeartCast 2: practical approach to the treatment of HFrEF
|
Jan 25, 2022 |
|
HeartCast 3: practical approach to the treatment of HFrEF
|
Jan 25, 2022 |
|
At a Glance: Approach to Ticagrelor-induced Dyspnea
|
Jan 25, 2022 |
|
At a glance: preventing cardiovascular thrombotic event after ACS
|
Jan 25, 2022 |
|
Dual RAAS inhibition in the treatment of systolic heart failure; at a glance Part two: Eplerenone in the guidelines
|
Jan 25, 2022 |
|
Cardiopoint (12): Two-Drug Combinations as First-Step Antihypertensive treatment
|
Jan 25, 2022 |
|
HeartCast 1: practical approach to the treatment of HFrEF
|
Jan 25, 2022 |
|
Self-measured blood pressure monitoring at home
|
Jan 25, 2022 |
|
CardioPoint (10): The growing burden of cardiovascular diseases
|
Jan 25, 2022 |
|
What is new in the 2020 ESC Guideline for the diagnosis and management of Atrial Fibrillation
|
Jan 25, 2022 |
|
CardioPoint (11): Antithrombotic therapy in patients with AF treated with OAC undergoing PCI
|
Jan 25, 2022 |
|
What is new in the 2020 ESC Guideline for the diagnosis and management of AF
|
Jan 25, 2022 |
|
Cardiopoint (13): Management of stage 1 hypertension in adults with low cardiovascular risk
|
Jan 25, 2022 |
|
Dual RAAS inhibition in the treatment of systolic heart failure; at a glance Part one: Eplerenone in the pipeline
|
Jan 25, 2022 |
|
Apixaban Hub (4)
|
Jan 25, 2022 |
|
CardioPoint (1): Statins-Who is eligible?-Which dose?
|
Jan 18, 2022 |
|
Guideline Made Easy (5)
|
Jan 18, 2022 |
|
CardioPoint (3): NOACs in Elderly
|
Jan 18, 2022 |
|
CardioPoint (2): NOAC Monitoring, Do NOACs Need Monitoring?
|
Jan 18, 2022 |
|
PCSK9 Inhibition from bench to bedside (4)
|
Jan 17, 2022 |
|
PCSK9 Inhibition from bench to bedside (1)
|
Jan 17, 2022 |
|
CardioPoint (6): Treatment Target & Goal for LDL-Cholesterol
|
Jan 17, 2022 |
|
Guideline Made Easy (1)
|
Jan 17, 2022 |
|
Apixaban Hub (1)
|
Jan 17, 2022 |
|
Guideline Made Easy (4)
|
Jan 17, 2022 |
|
At a glance: ACEI and ARB in COVID-19 Era
|
Jan 17, 2022 |
|
Apixaban Hub (2)
|
Jan 17, 2022 |
|
At a glance; How dual pathway found its way into ESC guidelines?
|
Jan 17, 2022 |
|
What is new in the 2020 ESC Guideline for the diagnosis and management of AF
|
Jan 17, 2022 |
|
PCSK9 Inhibition from bench to bedside (2)
|
Jan 17, 2022 |
|
CardioPoint (4): Fixed-Dose Combination Pills in the Management of Hypertension
|
Jan 17, 2022 |
|
Guideline Made Easy (3)
|
Jan 17, 2022 |
|
Cardiac involvement in COVID-19 infection
|
Jan 17, 2022 |
|
CardioPoint (8): When to consider drug treatment in hypertension?
|
Jan 17, 2022 |
|
At a glance; FDC role in HTN Pharmacotherapy
|
Jan 17, 2022 |
|
Apixaban Hub (3)
|
Jan 17, 2022 |
|
PCSK9 Inhibition from bench to bedside (3)
|
Jan 17, 2022 |
|
CardioPoint (5): NOACs in CKD
|
Jan 17, 2022 |
|
Guideline Made Easy (2)
|
Jan 17, 2022 |
|
CardioPoint (7): Selecting appropriate NOAC
|
Jan 17, 2022 |
|
CardioPoint (9): Once vs. twice-daily NOACs and adherence considerations
|
Jan 17, 2022 |
|
At a glance; Place of FDC in CV outcomes
|
Jan 17, 2022 |
|
Guideline Made Easy (6)
|
Jan 17, 2022 |
|
DiaBeat: The Beating Heart of Diabetes (4th session)
|
Jan 15, 2022 |
|
DiaBeat: The Beating Heart of Diabetes (3rd session)
|
Jan 15, 2022 |
|
DiaBeat: The Beating Heart of Diabetes (5th session)
|
Jan 15, 2022 |
|
Rivaroxaban vs Apixaban in major ischemic or hemorrhagic events in AF
|
Jan 15, 2022 |
|
Antiplatelet journal scan
|
Jan 15, 2022 |
|
Aspirin vs Clopidogrel for chronic maintenance monotherapy after PCI
|
Jan 15, 2022 |
|
Cardio-Watch Podcast: Episode 4, Dyslipidemia
|
Jan 15, 2022 |
|
Landmark trials of ESC 2021 congress
|
Jan 15, 2022 |
|
Impact: Statin treatment and muscle symptoms
|
Jan 15, 2022 |
|
Cardio-Watch Podcast: Episode 7, ESC 2021 special
|
Jan 15, 2022 |
|
Testing for Iron deficiency and use of Ferric Carboxymaltose in HF patients
|
Jan 15, 2022 |
|
Cardio-Watch podcast: Episode 2, Hypertension
|
Jan 15, 2022 |
|
Impact: DAPT vs. Aspirin in patients with stroke or TIA
|
Jan 15, 2022 |
|
Therapeutic anticoagulation with Heparin in critically and non-critically ill patients with COVID-19
|
Jan 15, 2022 |
|
Cardio-Watch Podcast: Episode 6, Electrophysiology
|
Jan 15, 2022 |
|
Effect of Neprilysin Inhibition on LV Remodeling in Asymptomatic LV Systolic Dysfunction After MI
|
Jan 15, 2022 |
|
A review on four landmark anti-platelet therapy trials
|
Jan 15, 2022 |
|
Cardio-Watch podcast: Episode 3, Atrial fibrillation and Flutter
|
Jan 15, 2022 |
|
Left Atrial Appendage Occlusion to prevent Stroke
|
Jan 15, 2022 |
|
Cardio-Watch Podcast: Episode 1, COVID-19 and the heart
|
Jan 15, 2022 |
|
Cardio-Watch Podcast: Episode 5, cardiometabolic disorders
|
Jan 15, 2022 |
|
Impact: No-LVT trial
|
Jan 15, 2022 |
|
Impact: the paradox of physical activity in cardiovascular disease
|
Jan 15, 2022 |
|
Safety and Efficacy of different antithrombotic strategies after TAVI
|
Jan 15, 2022 |
|
Midodrine for the prevention of vasovagal syndrome: a randomized clinical trial
|
Jan 15, 2022 |
|
Long-term event-free and overall survival with Dapagliflozin in HFrEF patients
|
Jan 15, 2022 |
|
Milrinone compared with Dobutamine in cardiogenic shock: DOREMI trial
|
Jan 15, 2022 |
|
Dapagliflozin in non-DM Patients with HF and Reduced EF
|
Jan 15, 2022 |
|
Benefits of Targeting for a
|
Jan 15, 2022 |
|
Electrical versus pharmacological cardioversion for acute AF in emergency settings
|
Jan 15, 2022 |
|
Daily Cardiology Journal Club: First Session – How to setup an effective Journal Club?
|
Jan 15, 2022 |
|
Dapagliflozin in concurrent Atrial Fibrillation and T2DM
|
Jan 15, 2022 |
|
Daily Cardiology Journal Club: First Session – How to setup an effective Journal Club?
|
Jan 15, 2022 |
|
Daily Cardiology Journal Club: 3rd Session – EMPEROR-REDUCED Trial
|
Jan 15, 2022 |
|
Predicting the Risk of Post-stroke Atrial Cardiopathy
|
Jan 15, 2022 |
|
Intensive LDL lowering beyond current recommendations for MACE prevention
|
Jan 15, 2022 |
|
Daily Cardiology Journal Club: 4th Session – EAST-AFNET4 Trial
|
Jan 15, 2022 |
|
OACs vs. antiplatelet or placebo for stroke prevention in patients with HF and sinus rhythm
|
Jan 15, 2022 |
|
Association of Anticoagulation Therapy with the Risk of Fracture in AF Patients
|
Jan 15, 2022 |
|
Intensive Blood Pressure lowering and the Concerns about Falling
|
Jan 15, 2022 |
|
Daily Cardiology Journal Club: Second Session – ISCHEMIA Trial
|
Jan 15, 2022 |
|
Complete vs. Culprit-only Revascularization in Patients with STEMI and Multi-Vessel Coronary Disease
|
Jan 15, 2022 |
|
SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in T2DM
|
Jan 15, 2022 |
|
Timing of Staged Non-Culprit Artery PCI in STEMI
|
Jan 15, 2022 |
|
Inclisiran for patients with ASCVD and elevated LDL
|
Jan 15, 2022 |
|
The Efficacy and Safety of Low-Dose Colchicine after MI
|
Jan 15, 2022 |
|
Optimal Medical Therapy vs. Revascularization in Chronic Coronary Syndrome
|
Jan 15, 2022 |
|
Antithrombotic treatment after CABG
|
Jan 15, 2022 |
|
Early Surgery or Conservative Care for Asymptomatic Aortic Stenosis
|
Jan 15, 2022 |
|
Triglyceride Lowering and Cardiovascular Risk Reduction
|
Jan 15, 2022 |
|
AF after Non-Cardiac Surgery Increases the Risk of Stroke
|
Jan 15, 2022 |
|
Inclisiran in Heterozygous Familial Hypercholesterolemia (HeFH) and Elevated LDL
|
Jan 15, 2022 |
|
Rivaroxaban vs. Vit K Antagonist in Antiphospholipid Syndrome
|
Jan 15, 2022 |
|
Ticagrelor with or without Aspirin in High-Risk patients after PCI
|
Jan 15, 2022 |
|
Lisinopril vs Carvedilol for Trastuzumab Cardiotoxicity in Breast Cancer
|
Jan 15, 2022 |
|
Acute vs Subacute Coronary Angiography in NSTEMI
|
Jan 15, 2022 |
|
Peri-operative beta-blockers in non-cardiac surgery
|
Jan 15, 2022 |
|
Myocardial Viability and Long-Term Outcomes in Ischemic Cardiomyopathy
|
Jan 15, 2022 |
|
OAC Monotherapy in Patients with Stable CAD and Non-valvular AF
|
Jan 15, 2022 |
|
Optimal Timing of P2Y12 Inhibitor Loading in Patients Undergoing PCI
|
Jan 15, 2022 |
|
Pantoprazole in Patients Receiving Rivaroxaban and/or Aspirin
|
Jan 15, 2022 |
|
Five-Year Outcomes after PCI or CABG for Left Main Coronary Disease
|
Jan 15, 2022 |
|
Risk of Mortality Following Catheter Ablation of AF
|
Jan 15, 2022 |
|
Restarting Antiplatelet After ICH Cuts Recurrence Risk in Half
|
Jan 15, 2022 |
|
Ezetimibe for the prevention of heart disease and death
|
Jan 15, 2022 |
|
Bedtime hypertension treatment improves cardiovascular risk reduction
|
Jan 15, 2022 |
|
Anticoagulation in HF and sinus rhythm
|
Jan 15, 2022 |
|
TAVR vs SAVR: insights from ACC.19
|
Jan 15, 2022 |
|
Optimal Duration of Aspirin Plus Clopidogrel After Ischemic Stroke or TIA
|
Jan 15, 2022 |
|
Antithrombotic Therapy after ACS or PCI in AF
|
Jan 15, 2022 |
|
Long-term outcomes of stenting and endarterectomy for symptomatic carotid stenosis
|
Jan 15, 2022 |
|
Canagliflozin and Renal Outcomes in T2Dm and Nephropathy
|
Jan 15, 2022 |
|
Hypertension and Hyperlipidemia Academy: 4th session
|
Jan 14, 2022 |
|
Ticagrelor Hub: when to use and which dose?
|
Jan 14, 2022 |
|
Management of dyslipidemia in diabetic patients
|
Jan 14, 2022 |
|
Primary prevention in dyslipidemia as the only cardiovascular risk factor
|
Jan 14, 2022 |
|
Umbrella Heart and Stroke: session 1, detecting & managing patients with PFO
|
Jan 14, 2022 |
|
Late-breaking Science in Cardiovascular disease prevention
|
Jan 14, 2022 |
|
DiaBeat: The Beating Heart of Diabetes (8th session)
|
Jan 14, 2022 |
|
Cardiometabolic Grand Round (5)
|
Jan 14, 2022 |
|
An introduction to a new series; HeartCast
|
Jan 14, 2022 |
|
The clinical landscape for Diabetes and Cardiovascular disease
|
Jan 14, 2022 |
|
Hypertension and Hyperlipidemia Academy 5, a hybrid event
|
Jan 14, 2022 |
|
DiaBeat: The Beating Heart of Diabetes (6th session)
|
Jan 14, 2022 |
|
Symptom matters: angina control in coronary artery disease
|
Jan 14, 2022 |
|
Marking the antiplatelet therapy maze in ACS
|
Jan 14, 2022 |
|
DiaBeat: The Beating Heart of Diabetes (7th session), a scientific debate
|
Jan 14, 2022 |
|
Antithrombotic lighthouse, Cases and Faces: antithrombotic therapy in CAD
|
Jan 14, 2022 |
|
From optimal medical therapy to revascularization in CCS
|
Jan 14, 2022 |
|
Cardiovascular complications of T2DM: the preventive role of SGLT2Is
|
Jan 14, 2022 |
|
Cardiometabolic Grand Round (4)
|
Jan 14, 2022 |
|
DCS 1400: session 8, Valvular Heart disease
|
Jan 14, 2022 |
|
Tailored Antithrombotic therapy for CCS patients
|
Jan 14, 2022 |
|
The evolution of antiplatelet therapy in CAD: a 45 year journey
|
Jan 14, 2022 |
|
Dual antiplatelet therapy in2021: Current recommendations
|
Jan 14, 2022 |
|
How to reduce the atherosclerotic cardiovascular risk
|
Jan 14, 2022 |
|
DiaBeat: The Beating Heart of Diabetes (1st session)
|
Jan 14, 2022 |
|
PCSK9 inhibitors place in patients with cardiometabolic diseases
|
Jan 14, 2022 |
|
Residents’ Island: Abidi CVD Prevention Academy
|
Jan 14, 2022 |
|
Cardiometabolic Grand Round (3)
|
Jan 13, 2022 |
|
7th Case: Thrombocytopenia
|
Jan 13, 2022 |
|
5th Case: Stable ASCVD
|
Jan 13, 2022 |
|
6th Case: Hepatic Impairment
|
Jan 13, 2022 |
|
8th Case: Intracranial Bleed
|
Jan 13, 2022 |
|
10th Case: Drug Drug Interactions
|
Jan 13, 2022 |
|
9th Case: Renal Insufficiency
|
Jan 13, 2022 |
|
4th Case: Extreme Body Weights
|
Jan 13, 2022 |
|
3rd Case: AF & Artificial Heart Valves
|
Jan 13, 2022 |
|
2nd Case: Cancer associated VTE
|
Jan 13, 2022 |
|
1st Case: Elective PCI and AF
|
Jan 13, 2022 |
|
SGLT2 inhibition: A snapshot into their evolution
|
Jan 13, 2022 |
|
SGLT2 inhibition: Making waves in the heart failure landscape
|
Jan 12, 2022 |
|
Cardiometabolic Grand Round (2)
|
Jan 12, 2022 |
|
Paradigm Shift in Treating Intermediate Risk Pulmonary Embolism
|
Jan 11, 2022 |
|
How to Implement the Newest Diabetes Therapies in HF Treatment
|
Jan 11, 2022 |
|
What we learned from ESC Congress about HTN Management
|
Jan 11, 2022 |
|
VTE Prophylaxis in Patients with COVID-19
|
Jan 11, 2022 |
|
ESC 2020 Congress Coverage What is new on NSTE-ACS Guideline: a panel discussion
|
Jan 11, 2022 |
|
Diabetes and Cardiovascular Diseases
|
Jan 11, 2022 |
|
Smoking and the Heart the Struggle Continues
|
Jan 11, 2022 |
|
Ground-breaking research from ESC Congress 2020 (23)
|
Jan 11, 2022 |
|
Ground-breaking research from ESC Congress 2020 (21)
|
Jan 11, 2022 |
|
Ground-breaking research from ESC Congress 2020 (22)
|
Jan 11, 2022 |
|
Ground-breaking research from ESC Congress 2020 (15)
|
Jan 10, 2022 |
|
Ground-breaking research from ESC Congress 2020 (17)
|
Jan 10, 2022 |
|
Ground-breaking research from ESC Congress 2020 (9)
|
Jan 10, 2022 |
|
Ground-breaking research from ESC Congress 2020 (11)
|
Jan 10, 2022 |
|
Ground-breaking research from ESC Congress 2020 (14)
|
Jan 10, 2022 |
|
Ground-breaking research from ESC Congress 2020 (20)
|
Jan 10, 2022 |
|
Ground-breaking research from ESC Congress 2020 (19)
|
Jan 10, 2022 |
|
Ground-breaking research from ESC Congress 2020 (18)
|
Jan 10, 2022 |
|
Ground-breaking research from ESC Congress 2020 (4)
|
Jan 10, 2022 |
|
Ground-breaking research from ESC Congress 2020 (12)
|
Jan 10, 2022 |
|
Ground-breaking research from ESC Congress 2020 (16)
|
Jan 10, 2022 |
|
Ground-breaking research from ESC Congress 2020 (3)
|
Jan 10, 2022 |
|
Ground-breaking research from ESC Congress 2020 (1)
|
Jan 10, 2022 |
|
Ground-breaking research from ESC Congress 2020 (10)
|
Jan 10, 2022 |
|
Ground-breaking research from ESC Congress 2020
|
Jan 10, 2022 |
|
Ground-breaking research from ESC Congress 2020 (2)
|
Jan 10, 2022 |
|
Ground-breaking research from ESC Congress 2020 (5)
|
Jan 10, 2022 |
|
Ground-breaking research from ESC Congress 2020 (13)
|
Jan 10, 2022 |
|
Current Cardiology Practice of Antithrombotics in ASCVD: A Case Based Panel Discussion
|
Jan 10, 2022 |
|
Cardiometabolic Care Network
|
Jan 10, 2022 |
|
Shielding the Brain From Stroke
|
Jan 10, 2022 |
|
Ground-breaking research from ESC Congress 2020 (7)
|
Jan 10, 2022 |
|
Ground-breaking research from ESC Congress 2020 (8)
|
Jan 10, 2022 |
|
Ground-breaking research from ESC Congress 2020 (6)
|
Jan 10, 2022 |
|
Low-dose Rivaroxaban in Management of PAD Patients
|
Jan 10, 2022 |
|
Low-dose Rivaroxaban in Management of Post-Revascularized CAD Patients
|
Jan 10, 2022 |
|
COVID-19 and thrombotic or thromboembolic disease: implication for prevention, antithrombotic therapy, and follow up
|
Jan 10, 2022 |
|
Chemoprophylaxis of SARS-CoV-2 Infection (COVID-19)Hydroxychloroquine: A magic bullet?
|
Jan 10, 2022 |
|
COVID and Cardiometabolic Challenges
|
Jan 10, 2022 |
|
The evolving pandemic of COVID-19 and invasive cardiology consideration
|
Jan 09, 2022 |
|
COVID-19 Cath Lab Implications
|
Jan 09, 2022 |
|
COVID-19 Sharing Facts, Not the Fear
|
Jan 09, 2022 |
|
Ischemic Cardiomyopathy to be Revascularized and How?
|
Jan 09, 2022 |
|
How to Select Appropriate Testing?
|
Jan 09, 2022 |
|
Anti-ischemic Medications
|
Jan 09, 2022 |